Fetal hemoglobin and hemolysis markers in sickle cell anemia☆
نویسندگان
چکیده
It has been known for many years that high levels of fetal hemoglobin (Hb F) have an important clinical benefit in patients with sickle cell anemia (SCA). This knowledge was initially based on the observation that populations of Indian and Arabian SCA patients with high Hb F levels have a milder clinical form of the disease.1 Later on, epidemiological studies demonstrated that patients with Hb F levels above 20% had consistently lower rates of recurrent clinical events such as vaso-occlusive crises, acute chest syndrome and hospitalizations, and patients with Hb F levels above 10% had reduced occurrence of aseptic necrosis and strokes.2 A significant increase of 1.0 g/dL in hemoglobin levels in the high Hb F group was also noted, indicating a reduction in the rate of hemolysis.2 A study of life expectancy in sickle cell disease (SCD) patients demonstrated an improved survival of patients with Hb F levels above 8.6% and an increased risk of early death in patients with low Hb F levels.3 The presence of Hb F in red blood cells (RBCs) alters contact between RBCs with hemoglobin S (Hb S) and inhibits the formation of polymers in deoxygenated RBCs. Hb F is produced by a fraction of RBCs denominated F-cells, which contain variable concentrations of Hb F.4 Studies suggest that when F-cells contain around 10 pg of Hb F there is complete inhibition of polymer formation even when oxygen saturation is from 40% to 70%.5 F-cells are RBCs that have a much longer survival than non-F-cells, with their survival being related to their Hb F content: the higher the Hb F content the longer the life span of F-cells.6 The survival of non-F-cells is inversely correlated
منابع مشابه
The Influence of Fetal Hemoglobin on Clinical and Hematological Variables of Children and Adolescents with Sickle Cell Anemia in Basra, Southern Iraq
Background: There are many parameters that modulate the severity of sickle cell anemia. Fetal hemoglobin (Hb F) is one of these major variables. However, its effect is clinically inconsistent. We conducted a descriptive study to assess the influence of Hb F on clinical events and hematological variables in patients with sickle cell anemia. Methods: 151 patients with sickle cell anemia with a st...
متن کاملBeta-Globin Gene Cluster Haplotypes in Iranian Sickle Cell Patients: Relation to Some Hematologic
Background: Sickle cell anemia is relatively common in Khuzestan province located in Southwest Iran. The characteristics of sickle cell disease in Iran are apparently different from other regions some of these characteristics might be related to β-chain haplotypes. The purpose of this study was to determine the frequency of β-chain haplotypes in 50 patients with homozygous sickle cell anemia in...
متن کاملSide Effects of Hydroxyurea in Patients with Sickle Cell Anemia
Background: Hemoglobin S arises is the result of a point mutation (A-T) in the sixth codon on the -globin gene on chromosome 11 causing sickle cell anemia. The presence of fetal hemoglobin in infancy plays a relatively protective role for vaso-occlusive symptoms that are the major contributor for the morbidity and mortality among patients with sickle cell anemia. hydroxyurea, an s-phase-specif...
متن کاملPattern of hemolysis parameters and association with fetal hemoglobin in sickle cell anemia patients in steady state
OBJECTIVE This study aimed to evaluate the influence of fetal hemoglobin (Hb F) on hemolysis biomarkers in sickle cell anemia patients. METHODS Fifty adult sickle cell anemia patients were included in the study. All patients were taking hydroxyurea for at least six months and were followed at the outpatient clinic of a hospital in Fortaleza, Ceará, Brazil. The control group consisted of 20 he...
متن کاملCirculating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin.
Hematologic and hemorheological determinants of resting and exercise-induced hemoglobin oxygen desaturation in children with sickle cell disease Xavier Waltz, Marc Romana, Marie-Laure LalanneMistrih, Roberto F. Machado, Yann Lamarre, Vanessa Tarer, Marie-Dominique Hardy-Dessources, Benoît Tressières, Lydia Divialle-Doumdo, Marie Petras, Frederic Maillard, Maryse Etienne-Julan, and Philippe Connes
متن کاملSide effects of hydroxyurea in patients with Thalassemia major and thalassemia intermedia and sickle cell anemia
Background Sickle hemoglobin is the most common abnormal hemoglobin in the United States. Hemoglobin S arises as a result of a single amino acid substitution (glutamic acid to valin at position 6 of the β-globine chain). The presence of fetal hemoglobin (HbF) plays a relatively protective role since a significant amount of HbF interferes with HbS polymerization, the pathogenesis mechanism of ...
متن کامل